Properties (63)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:Company
|
| gptkbp:accreditation |
ISO_certified
|
| gptkbp:acquisition |
Actavis'_generic_business_in_the_US
|
| gptkbp:awards |
Industry recognition awards
|
| gptkbp:businessModel |
Generic_and_branded_pharmaceuticals
|
| gptkbp:certifications |
FDA_approved
|
| gptkbp:clinicalTrials |
Ongoing
Conducts clinical research studies Phase I, II, and III trials |
| gptkbp:collaborations |
With academic institutions
|
| gptkbp:communityEngagement |
Health awareness programs
|
| gptkbp:communitySupport |
Supports local health initiatives
|
| gptkbp:corporateSocialResponsibility |
Engages in CSR activities
|
| gptkbp:customerBase |
Hospitals and pharmacies
|
| gptkbp:customerService |
Dedicated customer service team
|
| gptkbp:distribution |
Across_the_United_States
|
| gptkbp:employees |
Over 1,000
|
| gptkbp:expansion |
Into_the_US_market
|
| gptkbp:financialPerformance |
Strong financial performance
|
| gptkbp:financials |
Supports healthcare initiatives.
|
| gptkbp:focus |
Research_and_Development
|
| gptkbp:founded |
1984
|
| gptkbp:globalPresence |
Operations in multiple countries
|
| gptkbp:hasResearchInterest |
Conducts market research
|
| gptkbp:headCoach |
Approximately 1,500
|
| gptkbp:headquarters |
gptkb:New_Jersey,_USA
|
| https://www.w3.org/2000/01/rdf-schema#label |
Intas Pharmaceuticals USA
|
| gptkbp:industry |
Pharmaceuticals
|
| gptkbp:innovation |
Focus on advanced drug delivery systems
|
| gptkbp:investmentFocus |
Invests in biotechnology
|
| gptkbp:market |
gptkb:North_America
|
| gptkbp:marketSegment |
Focus on affordability
|
| gptkbp:parentCompany |
gptkb:Intas_Pharmaceuticals_Ltd.
|
| gptkbp:partnerships |
Various healthcare organizations
With research organizations With hospitals and clinics |
| gptkbp:patentCitation |
Multiple patents in pharmaceuticals
|
| gptkbp:productLine |
Topicals
Injectables Oral solids Transdermals |
| gptkbp:productQuality |
High product quality standards
|
| gptkbp:products |
Biosimilars
New product development initiatives Generic_drugs |
| gptkbp:regulatoryCompliance |
Meets_FDA_regulations
|
| gptkbp:research_areas |
Cardiology
Oncology Diabetes Neurology Infectious Diseases |
| gptkbp:researchFocus |
Novel drug formulations
|
| gptkbp:researchInterest |
Multiple_locations_in_the_US
|
| gptkbp:revenue |
Over $500 million
|
| gptkbp:services |
Contract manufacturing
|
| gptkbp:strategicGoals |
Expand market share
|
| gptkbp:subsidiary |
gptkb:Intas_Pharmaceuticals_Ltd.
|
| gptkbp:supplyChain |
Global supply chain
Efficient supply chain management Robust supply chain network |
| gptkbp:sustainabilityInitiatives |
Environmental responsibility
|
| gptkbp:training |
Continuous professional development
|
| gptkbp:website |
www.intaspharma.com
|